Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

The Epigenomics of Pituitary Adenoma.

Hauser BM, Lau A, Gupta S, Bi WL, Dunn IF.

Front Endocrinol (Lausanne). 2019 May 14;10:290. doi: 10.3389/fendo.2019.00290. eCollection 2019. Review.

2.

Adverse Events After Microvascular Decompression: A National Surgical Quality Improvement Program Analysis.

Cote DJ, Dasenbrock HH, Gormley WB, Smith TR, Dunn IF.

World Neurosurg. 2019 May 11. pii: S1878-8750(19)31296-3. doi: 10.1016/j.wneu.2019.05.022. [Epub ahead of print]

PMID:
31082546
3.

Iatrogenic Inner Ear Dehiscence After Lateral Skull Base Surgery: Therapeutic Dilemma and Treatment Options.

Bartholomew RA, Poe D, Dunn IF, Smith TR, Corrales CE.

Otol Neurotol. 2019 Apr;40(4):e399-e404. doi: 10.1097/MAO.0000000000002162.

PMID:
30870369
4.

Mismatch repair deficiency in high-grade meningioma: a rare but recurrent event associated with dramatic immune activation and clinical response to PD-1 blockade.

Dunn IF, Du Z, Touat M, Sisti MB, Wen PY, Umeton R, Dubuc AM, Ducar M, Canoll PD, Severson E, Elvin JA, Ramkissoon SH, Lin JR, Cabrera L, Acevedo B, Sorger PK, Ligon KL, Santagata S, Reardon DA.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.18.00190. Epub 2018 Nov 27. No abstract available.

5.

Variation in Coding Practices for Vestibular Schwannoma Surgery.

Bi WL, Mooney MA, Yoon S, Gupta S, Lawton MT, Almefty KK, Corrales CE, Dunn IF.

J Neurol Surg B Skull Base. 2019 Feb;80(1):96-102. doi: 10.1055/s-0038-1667124. Epub 2018 Jul 16.

PMID:
30733907
6.

Artificial intelligence in cancer imaging: Clinical challenges and applications.

Bi WL, Hosny A, Schabath MB, Giger ML, Birkbak NJ, Mehrtash A, Allison T, Arnaout O, Abbosh C, Dunn IF, Mak RH, Tamimi RM, Tempany CM, Swanton C, Hoffmann U, Schwartz LH, Gillies RJ, Huang RY, Aerts HJWL.

CA Cancer J Clin. 2019 Mar;69(2):127-157. doi: 10.3322/caac.21552. Epub 2019 Feb 5. Review.

7.

Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial.

Wen PY, Touat M, Alexander BM, Mellinghoff IK, Ramkissoon S, McCluskey CS, Pelton K, Haidar S, Basu SS, Gaffey SC, Brown LE, Martinez-Ledesma JE, Wu S, Kim J, Wei W, Park MA, Huse JT, Kuhn JG, Rinne ML, Colman H, Agar NYR, Omuro AM, DeAngelis LM, Gilbert MR, de Groot JF, Cloughesy TF, Chi AS, Roberts TM, Zhao JJ, Lee EQ, Nayak L, Heath JR, Horky LL, Batchelor TT, Beroukhim R, Chang SM, Ligon AH, Dunn IF, Koul D, Young GS, Prados MD, Reardon DA, Yung WKA, Ligon KL.

J Clin Oncol. 2019 Mar 20;37(9):741-750. doi: 10.1200/JCO.18.01207. Epub 2019 Feb 4.

8.

Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.

Zhu H, Bi WL, Aizer A, Hua L, Tian M, Den J, Tang H, Chen H, Wang Y, Mao Y, Dunn IF, Xie Q, Gong Y.

Cancer Med. 2019 Jan;8(1):13-20. doi: 10.1002/cam4.1531.

9.

Imaging and diagnostic advances for intracranial meningiomas.

Huang RY, Bi WL, Griffith B, Kaufmann TJ, la Fougère C, Schmidt NO, Tonn JC, Vogelbaum MA, Wen PY, Aldape K, Nassiri F, Zadeh G, Dunn IF; International Consortium on Meningiomas .

Neuro Oncol. 2019 Jan 14;21(Supplement_1):i44-i61. doi: 10.1093/neuonc/noy143.

10.

Molecular and translational advances in meningiomas.

Suppiah S, Nassiri F, Bi WL, Dunn IF, Hanemann CO, Horbinski CM, Hashizume R, James CD, Mawrin C, Noushmehr H, Perry A, Sahm F, Sloan A, Von Deimling A, Wen PY, Aldape K, Zadeh G; International Consortium on Meningiomas .

Neuro Oncol. 2019 Jan 14;21(Supplement_1):i4-i17. doi: 10.1093/neuonc/noy178.

11.

Advances in multidisciplinary therapy for meningiomas.

Brastianos PK, Galanis E, Butowski N, Chan JW, Dunn IF, Goldbrunner R, Herold-Mende C, Ippen FM, Mawrin C, McDermott MW, Sloan A, Snyder J, Tabatabai G, Tatagiba M, Tonn JC, Wen PY, Aldape K, Nassiri F, Zadeh G, Jenkinson MD, Raleigh DR; International Consortium on Meningiomas .

Neuro Oncol. 2019 Jan 14;21(Supplement_1):i18-i31. doi: 10.1093/neuonc/noy136.

12.

Neurosurgical Resection and Stereotactic Radiation Versus Stereotactic Radiation Alone in Patients with a Single or Solitary Brain Metastasis.

Lamba N, Cagney DN, Brigell RH, Martin AM, Besse LA, Catalano PJ, Phillips JG, Pashtan IM, Bi WL, Claus EB, Golby AJ, Dunn IF, Smith TR, Tanguturi SK, Haas-Kogan DA, Alexander BM, Aizer AA.

World Neurosurg. 2019 Feb;122:e1557-e1561. doi: 10.1016/j.wneu.2018.11.100. Epub 2018 Nov 22.

PMID:
30471438
13.

Predicting Readmission and Reoperation for Benign Cranial Nerve Neoplasms: A Nationwide Analysis.

Gupta S, Ahmed AK, Bi WL, Dawood HY, Iorgulescu JB, Corrales CE, Dunn IF, Smith TR.

World Neurosurg. 2019 Jan;121:e223-e229. doi: 10.1016/j.wneu.2018.09.081. Epub 2018 Sep 25.

PMID:
30261394
14.

Demonstration of Infectious Transgression Through the Skull Base Occurring 9 Years After Pituitary Adenoma Resection.

Liu J, Penn DL, Katznelson E, Safain MG, Dunn IF, Laws ER Jr.

World Neurosurg. 2018 Nov;119:215-219. doi: 10.1016/j.wneu.2018.08.028. Epub 2018 Aug 13.

PMID:
30114535
15.

An updated assessment of morbidity and mortality following skull base surgical approaches.

Burton BN, Hu JQ, Jafari A, Urman RD, Dunn IF, Bi WL, DeConde AS, Gabriel RA.

Clin Neurol Neurosurg. 2018 Aug;171:109-115. doi: 10.1016/j.clineuro.2018.06.015. Epub 2018 Jun 10.

PMID:
29906680
16.

Craniopharyngioma: a roadmap for scientific translation.

Gupta S, Bi WL, Giantini Larsen A, Al-Abdulmohsen S, Abedalthagafi M, Dunn IF.

Neurosurg Focus. 2018 Jun;44(6):E12. doi: 10.3171/2018.3.FOCUS1861.

PMID:
29852761
17.

High-grade meningiomas: biology and implications.

Bi WL, Prabhu VC, Dunn IF.

Neurosurg Focus. 2018 Apr;44(4):E2. doi: 10.3171/2017.12.FOCUS17756.

PMID:
29606053
18.

Medical management of meningioma in the era of precision medicine.

Gupta S, Bi WL, Dunn IF.

Neurosurg Focus. 2018 Apr;44(4):E3. doi: 10.3171/2018.1.FOCUS17754.

PMID:
29606052
19.

3D printing and intraoperative neuronavigation tailoring for skull base reconstruction after extended endoscopic endonasal surgery: proof of concept.

Essayed WI, Unadkat P, Hosny A, Frisken S, Rassi MS, Mukundan S, Weaver JC, Al-Mefty O, Golby AJ, Dunn IF.

J Neurosurg. 2018 Mar 2;130(1):248-255. doi: 10.3171/2017.9.JNS171253.

20.

Orbital leiomyosarcoma metastasis presenting prior to diagnosis of the primary tumor.

Rasool N, Lefebvre DR, Latina MA, Dunn IF, Santagata S, Freitag SK, Cestari DM.

Digit J Ophthalmol. 2017 Dec 31;23(4):22-26. doi: 10.5693/djo.02.2017.02.004. eCollection 2017.

21.

Genomic Alterations in Sporadic Pituitary Tumors.

Bi WL, Larsen AG, Dunn IF.

Curr Neurol Neurosci Rep. 2018 Feb 2;18(1):4. doi: 10.1007/s11910-018-0811-0. Review.

PMID:
29396598
22.

Clinical applications of dynamic CT angiography for intracranial lesions.

Gupta S, Bi WL, Mukundan S, Al-Mefty O, Dunn IF.

Acta Neurochir (Wien). 2018 Apr;160(4):675-680. doi: 10.1007/s00701-018-3465-4. Epub 2018 Jan 20.

PMID:
29353408
23.

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Imaging in the Diagnosis and Management of Patients With Vestibular Schwannomas.

Dunn IF, Bi WL, Mukundan S, Delman BN, Parish J, Atkins T, Asher AL, Olson JJ.

Neurosurgery. 2018 Feb 1;82(2):E32-E34. doi: 10.1093/neuros/nyx510.

PMID:
29309686
24.

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Surgical Resection for the Treatment of Patients With Vestibular Schwannomas.

Hadjipanayis CG, Carlson ML, Link MJ, Rayan TA, Parish J, Atkins T, Asher AL, Dunn IF, Corrales CE, Van Gompel JJ, Sughrue M, Olson JJ.

Neurosurgery. 2018 Feb 1;82(2):E40-E43. doi: 10.1093/neuros/nyx512.

PMID:
29309632
25.

Erratum: Genomic landscape of high-grade meningiomas.

Bi WL, Greenwald NF, Abedalthagafi M, Wala J, Gibson WJ, Agarwalla PK, Horowitz P, Schumacher SE, Esaulova E, Mei Y, Chevalier A, A Ducar M, Thorner AR, van Hummelen P, O Stemmer-Rachamimov A, Artyomov M, Al-Mefty O, Dunn GP, Santagata S, Dunn IF, Beroukhim R.

NPJ Genom Med. 2017 Sep 4;2:26. doi: 10.1038/s41525-017-0023-6. eCollection 2017.

26.

Management of intracranial melanomas in the era of precision medicine.

Young GJ, Bi WL, Wu WW, Johanns TM, Dunn GP, Dunn IF.

Oncotarget. 2017 Jul 13;8(51):89326-89347. doi: 10.18632/oncotarget.19223. eCollection 2017 Oct 24. Review.

27.

Radiographic prediction of meningioma grade by semantic and radiomic features.

Coroller TP, Bi WL, Huynh E, Abedalthagafi M, Aizer AA, Greenwald NF, Parmar C, Narayan V, Wu WW, Miranda de Moura S, Gupta S, Beroukhim R, Wen PY, Al-Mefty O, Dunn IF, Santagata S, Alexander BM, Huang RY, Aerts HJWL.

PLoS One. 2017 Nov 16;12(11):e0187908. doi: 10.1371/journal.pone.0187908. eCollection 2017.

28.

Prosthetic Replacement of the Ocular Surface Ecosystem Treatment of Ocular Surface Disease After Skull Base Tumor Resection.

Kloek CE, Jeng-Miller KW, Jacobs DS, Dunn IF.

World Neurosurg. 2018 Feb;110:e124-e128. doi: 10.1016/j.wneu.2017.10.111. Epub 2017 Oct 28.

PMID:
29107724
29.

Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone.

Arvold ND, Shi DD, Aizer AA, Norden AD, Reardon DA, Lee EQ, Nayak L, Dunn IF, Golby AJ, Johnson MD, Claus EB, Chiocca EA, Ligon KL, Wen PY, Alexander BM.

J Neurooncol. 2017 Dec;135(3):581-591. doi: 10.1007/s11060-017-2611-9. Epub 2017 Oct 3.

PMID:
28975467
30.

Natural history of cranial fibrous dysplasia revealed during long-term follow-up: Case report and literature review.

Penn DL, Tartarini RJ, Glass CH, De Girolami U, Zamani AA, Dunn IF.

Surg Neurol Int. 2017 Sep 6;8:209. doi: 10.4103/sni.sni_7_17. eCollection 2017.

31.

Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling.

Mei Y, Du Z, Hu C, Greenwald NF, Abedalthagafi M, Agar NYR, Dunn GP, Bi WL, Santagata S, Dunn IF.

Cell Commun Signal. 2017 Sep 18;15(1):34. doi: 10.1186/s12964-017-0189-7.

32.

Current and emerging principles in surgery for meningioma.

Bi WL, Dunn IF.

Chin Clin Oncol. 2017 Jul;6(Suppl 1):S7. doi: 10.21037/cco.2017.06.10. Review.

33.

Genomic landscape of high-grade meningiomas.

Bi WL, Greenwald NF, Abedalthagafi M, Wala J, Gibson WJ, Agarwalla PK, Horowitz P, Schumacher SE, Esaulova E, Mei Y, Chevalier A, Ducar M, Thorner AR, van Hummelen P, Stemmer-Rachamimov A, Artyomov M, Al-Mefty O, Dunn GP, Santagata S, Dunn IF, Beroukhim R.

NPJ Genom Med. 2017;2. pii: 15. doi: 10.1038/s41525-017-0014-7. Epub 2017 Apr 26. Erratum in: NPJ Genom Med. 2017 Sep 4;2:26.

34.

Unplanned Reoperation After Craniotomy for Tumor: A National Surgical Quality Improvement Program Analysis.

Dasenbrock HH, Yan SC, Chavakula V, Gormley WB, Smith TR, Claus EB, Dunn IF.

Neurosurgery. 2017 Nov 1;81(5):761-771. doi: 10.1093/neuros/nyx089.

PMID:
28655201
35.

Genomic profile of human meningioma cell lines.

Mei Y, Bi WL, Greenwald NF, Agar NY, Beroukhim R, Dunn GP, Dunn IF.

PLoS One. 2017 May 26;12(5):e0178322. doi: 10.1371/journal.pone.0178322. eCollection 2017.

36.

Pediatric Clival Chordoma: A Curable Disease that Conforms to Collins' Law.

Rassi MS, Hulou MM, Almefty K, Bi WL, Pravdenkova S, Dunn IF, Smith TR, Al-Mefty O.

Neurosurgery. 2018 May 1;82(5):652-660. doi: 10.1093/neuros/nyx254.

PMID:
28521059
37.

Clinical Identification of Oncogenic Drivers and Copy-Number Alterations in Pituitary Tumors.

Bi WL, Greenwald NF, Ramkissoon SH, Abedalthagafi M, Coy SM, Ligon KL, Mei Y, MacConaill L, Ducar M, Min L, Santagata S, Kaiser UB, Beroukhim R, Laws ER Jr, Dunn IF.

Endocrinology. 2017 Jul 1;158(7):2284-2291. doi: 10.1210/en.2016-1967.

38.

Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study.

Cagney DN, Martin AM, Catalano PJ, Redig AJ, Lin NU, Lee EQ, Wen PY, Dunn IF, Bi WL, Weiss SE, Haas-Kogan DA, Alexander BM, Aizer AA.

Neuro Oncol. 2017 Oct 19;19(11):1511-1521. doi: 10.1093/neuonc/nox077.

39.

Readmission After Craniotomy for Tumor: A National Surgical Quality Improvement Program Analysis.

Dasenbrock HH, Yan SC, Smith TR, Valdes PA, Gormley WB, Claus EB, Dunn IF.

Neurosurgery. 2017 Apr 1;80(4):551-562. doi: 10.1093/neuros/nyw062.

PMID:
28362921
40.

Delayed Carotid Pseudoaneurysms from Iatrogenic Clival Meningeal Branches Avulsion: Recognition and Proposed Management.

Almefty R, Dunn IF, Aziz-Sultan MA, Al-Mefty O.

World Neurosurg. 2017 Aug;104:736-744. doi: 10.1016/j.wneu.2017.03.016. Epub 2017 Mar 12.

PMID:
28300709
41.

Readmission and Other Adverse Events after Transsphenoidal Surgery: Prevalence, Timing, and Predictive Factors.

Cote DJ, Dasenbrock HH, Muskens IS, Broekman MLD, Zaidi HA, Dunn IF, Smith TR, Laws ER Jr.

J Am Coll Surg. 2017 May;224(5):971-979. doi: 10.1016/j.jamcollsurg.2017.02.015. Epub 2017 Mar 6.

PMID:
28279778
42.

Hybrid Surgery Management of Giant Hypervascular Tumors: Intraoperative Endovascular Embolization with Microsurgical Resection.

Almefty RO, Patel NJ, See AP, Dunn IF, Al-Mefty O, Aziz-Sultan MA.

World Neurosurg. 2017 Jun;102:157-166. doi: 10.1016/j.wneu.2017.02.092. Epub 2017 Mar 1.

PMID:
28259671
43.

Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas.

Shankar GM, Abedalthagafi M, Vaubel RA, Merrill PH, Nayyar N, Gill CM, Brewster R, Bi WL, Agarwalla PK, Thorner AR, Reardon DA, Al-Mefty O, Wen PY, Alexander BM, van Hummelen P, Batchelor TT, Ligon KL, Ligon AH, Meyerson M, Dunn IF, Beroukhim R, Louis DN, Perry A, Carter SL, Giannini C, Curry WT Jr, Cahill DP, Barker FG 2nd, Brastianos PK, Santagata S.

Neuro Oncol. 2017 Apr 1;19(4):535-545. doi: 10.1093/neuonc/now235.

44.

Rapid Mass Spectrometry Imaging to Assess the Biochemical Profile of Pituitary Tissue for Potential Intraoperative Usage.

Huang KT, Ludy S, Calligaris D, Dunn IF, Laws E, Santagata S, Agar NY.

Adv Cancer Res. 2017;134:257-282. doi: 10.1016/bs.acr.2016.11.006. Epub 2016 Dec 28. Review.

PMID:
28110653
45.

Timing of Decompressive Hemicraniectomy for Stroke: A Nationwide Inpatient Sample Analysis.

Dasenbrock HH, Robertson FC, Vaitkevicius H, Aziz-Sultan MA, Guttieres D, Dunn IF, Du R, Gormley WB.

Stroke. 2017 Mar;48(3):704-711. doi: 10.1161/STROKEAHA.116.014727. Epub 2017 Jan 20.

PMID:
28108618
46.

Superior semicircular canal dehiscence syndrome.

Bi WL, Brewster R, Poe D, Vernick D, Lee DJ, Eduardo Corrales C, Dunn IF.

J Neurosurg. 2017 Dec;127(6):1268-1276. doi: 10.3171/2016.9.JNS16503. Epub 2017 Jan 13. Review.

PMID:
28084916
47.

Impact of operative length on post-operative complications in meningioma surgery: a NSQIP analysis.

Karhade AV, Fandino L, Gupta S, Cote DJ, Iorgulescu JB, Broekman ML, Aglio LS, Dunn IF, Smith TR.

J Neurooncol. 2017 Jan;131(1):59-67. doi: 10.1007/s11060-016-2262-2. Epub 2016 Nov 18.

PMID:
27864707
48.

The genomic landscape of schwannoma.

Agnihotri S, Jalali S, Wilson MR, Danesh A, Li M, Klironomos G, Krieger JR, Mansouri A, Khan O, Mamatjan Y, Landon-Brace N, Tung T, Dowar M, Li T, Bruce JP, Burrell KE, Tonge PD, Alamsahebpour A, Krischek B, Agarwalla PK, Bi WL, Dunn IF, Beroukhim R, Fehlings MG, Bril V, Pagnotta SM, Iavarone A, Pugh TJ, Aldape KD, Zadeh G.

Nat Genet. 2016 Nov;48(11):1339-1348. doi: 10.1038/ng.3688. Epub 2016 Oct 10.

PMID:
27723760
49.

Predictors of aggressive clinical phenotype among immunohistochemically confirmed atypical adenomas.

Zaidi HA, Cote DJ, Dunn IF, Laws ER Jr.

J Clin Neurosci. 2016 Dec;34:246-251. doi: 10.1016/j.jocn.2016.09.014. Epub 2016 Oct 17.

PMID:
27765563
50.

Landscape of Genomic Alterations in Pituitary Adenomas.

Bi WL, Horowitz P, Greenwald NF, Abedalthagafi M, Agarwalla PK, Gibson WJ, Mei Y, Schumacher SE, Ben-David U, Chevalier A, Carter S, Tiao G, Brastianos PK, Ligon AH, Ducar M, MacConaill L, Laws ER Jr, Santagata S, Beroukhim R, Dunn IF.

Clin Cancer Res. 2017 Apr 1;23(7):1841-1851. doi: 10.1158/1078-0432.CCR-16-0790. Epub 2016 Oct 5.

Supplemental Content

Support Center